SCHEMBL4893134

SCHEMBL4893134

Cc1ccc(CNC(=O)CCSC2CCCC2)o1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.48
MAPT P10636 5/20 0.48
LMNA P02545 2/20 0.48
MAPK1 P28482 2/20 0.46
KMT2A Q03164 5/20 0.46
PKM P14618 5/20 0.43
HTT P42858 2/20 0.43
POLB P06746 1/20 0.42
MEN1 O00255 3/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 1/20 0.41
RECQL P46063 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4886830 0.80 ALDH1A1 (0.51) ALDH1A1MAPTLMNAMAPK1KMT2A
SCHEMBL4895351 0.79 ALDH1A1 (0.67) ALDH1A1MAPTKMT2APOLBMEN1
SCHEMBL4886403 0.76 ALDH1A1 (0.48) ALDH1A1MAPTLMNAMAPK1KMT2A
SCHEMBL19712892 0.76 ALDH1A1 (0.55) ALDH1A1MAPTLMNAMAPK1KMT2A
SCHEMBL23200084 0.72 HPGD (0.58) ALDH1A1MAPTKMT2AHTTPOLB
SCHEMBL27357988 0.72 PKM (0.52) ALDH1A1MAPTKMT2APKMHTT
SCHEMBL14281351 0.72 ALDH1A1 (0.51) ALDH1A1MAPTLMNAMAPK1KMT2A
SCHEMBL19726937 0.72 ALDH1A1 (0.51) ALDH1A1MAPTLMNAKMT2APKM
SCHEMBL18415480 0.70 ALDH1A1 (0.51) ALDH1A1MAPTKMT2APKMPOLB
SCHEMBL7976745 0.68 ALDH1A1 (0.50) ALDH1A1MAPTKMT2APKMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080025940-A1 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof L'OREAL (FR) 2008-01-31 US disclosed
US-20080025940-A1 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof L'OREAL (FR) 2008-01-31 US disclosed
US-20080025940-A1 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof L'OREAL (FR) 2008-01-31 US disclosed
EP-1853352-A2 USE OF 3-SULFANYLPROPANAMIDE DERIVATIVES FOR STIMULATING HAIR AND EYELASH GROWTH AND/OR FOR STOPPING THE LOSS AND/OR LIMITING THE DEPIGMENTATION THEREOF L'Oréal (FR) 2007-11-14 EP disclosed
WO-2006079568-A2 USE OF 3-SULFANYLPROPANAMIDE DERIVATIVES FOR STIMULATING HAIR AND EYELASH GROWTH AND/OR FOR STOPPING THE LOSS AND/OR LIMITING THE DEPIGMENTATION THEREOF L'OREAL (FR) 2006-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080025940-A1 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof KRT18, TYR, MC1R ALDH1A1 1607/4885MAPT 1733/4885LMNA 1814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.